drugIndia
Cart
Already at best price
Glynet-PM2 Tablet ER

Glynet-PM2 Tablet ER

Glimepiride (2mg) + Pioglitazone (15mg) + Metformin (500mg)

Zeelab Pharmacy Pvt Ltd
Hypertension
24.0030.0020% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
24.0020% OFF
30.00

About This Medicine

Product description & overview

Glynet-PM2 Tablet ER: A Comprehensive Treatment Solution

Glynet-PM2 Tablet ER combines three powerful medications in a single tablet formulation for the treatment of Type 2 Diabetes Mellitus (T2DM).

Each tablet contains:

* Glimepiride (2mg): This sulfonylurea effectively lowers blood glucose by stimulating insulin release from the pancreas.
* Metformin (500mg): This biguanide acts on multiple metabolic pathways, primarily reducing hepatic glucose production and improving cellular glucose uptake.
* Pioglitazone (15mg): This thiazolidinedione increases insulin sensitivity in target tissues, contributing to reduced blood glucose levels.

Glynet-PM2 is a once-daily extended-release tablet that provides long-lasting blood sugar control.

This formulation offers convenience and improved patient adherence due to its consistent release profile. It's important to consult with your healthcare professional for proper diagnosis, treatment plan, and dosage guidance.

Note: This information should not replace professional medical advice or a consultation with your doctor.

Active composition

Glimepiride 2 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
2 mg

All Active Ingredients

Glimepiride2 mg
Pioglitazone15 mg
Metformin500 mg

Pioglitazone

Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glynet-PM2 Tablet ER.

High Risk

Pregnancy

Glynet-PM2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glynet-PM2 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glynet-PM2 Tablet ER may be needed. Please consult your doctor. Use of Glynet-PM2 Tablet ER is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glynet-PM2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glynet-PM2 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glynet-PM2 Tablet ER may be needed. Please consult your doctor. Use of Glynet-PM2 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glynet-PM2 Tablet ER

Products matching your search